» Dr. Jerika Lam
Assistant Professor, Pharmacy Practice

School of Pharmacy
Dr. Jerika Lam
Office Location:
Rinker Health Science Campus 207
Phone:
(714) 516-5479
Email:
Education
University of California, Los Angeles, Bachelor of Arts
University of Southern California, Doctor of Pharmacy
Biography

In addition to the degrees listed in the Education section above, Dr. Lam holds the following credentials: AAHIVE and FCSHP. Dr. Lam completed her Bachelor’s degree in Art History/Biology from the University of California Los Angeles in 1998. She received her Doctor of Pharmacy degree from the University of Southern California School of Pharmacy in 2003. She completed a PGY1 residency at the San Francisco Veterans Affairs Medical Center, and a two-year fellowship at USC School of Pharmacy in HIV pharmacotherapy and translational research. She joined Loma Linda University School of Pharmacy Department of Pharmacotherapy and Outcomes Science as Assistant Professor in 2007. She is credentialed by the American Academy of HIV Medicine since 2008. In 2012, Dr. Lam ventured into management with Kaiser Permanente. On June 1, 2014, Dr. Lam resumed her passion for academia and joined Chapman University School of Pharmacy Department of Pharmacy Practice as Assistant Professor.

Dr. Lam had established her ambulatory care practice sites at the Desert AIDS Project Clinic, Riverside Neighborhood Health Center and Perris Family Care Center clinics. She received the Preceptor of the Year in Ambulatory Care from LLU School of Pharmacy (2009). She also received the American Association of Colleges of Pharmacy (AACP)/Walmart Scholars Award as mentor (2010), and was recognized as Fellow of California Society of Health-System Pharmacists (2011).

Dr. Lam has presented papers at many pharmacy conferences. She has also been invited to speak on the topics of HIV, hepatitis C and other ambulatory care topics by nursing and pharmacy associations. Her area of research interests is in translational research in viral infections, and public health issues relating to the reduction of HIV stigma and the improvement of patient health outcomes and medication adherence.

Recent Creative, Scholarly Work and Publications
Lam JT, Lynch A, Gutierrez MA. Systemic Lupus Erythematosus. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Lippincott Williams & Wilkins (Eds.), 2017 (in press).
Gutierrez MA, Lam JT. Psychobiology and Psychopharmacology. In: Foundations of Psychiatric Mental Health Nursing, 8th Ed., Halter MJ (ed.), Elsevier, St. Louis, Missouri; 2017:36-61.
Lam, JT, Holt C. Viral Hepatitis. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Lippincott Williams & Wilkins (Eds.), 2017 (in press).
Lam J, Goad J. The burden of vaccine-preventable diseases in adults. Pharmacy Times, March 31, 2017.
Jordan R, Lam JT, Lyren A, et al. Actionable Patient Safety Solution (APSS) #3A: Medication Errors. Patient Safety Movement Foundation. February 2017.
Lam JT, Peters C, Barker S, et al. Actionable Patient Safety Solution (APSS) #3B: Antimicrobial Stewardship: The Role of A Pharmacy And The Microbiology Lab In Patient Safety. Patient Safety Movement Foundation. January 2017.
Lam JT, Barker S, Ramsay M, et al. Actionable Patient Safety Solution (APSS) #3C: Improve Prevention of Severe Hypoglycemia. Patient Safety Movement Foundation. January 2017.
Yang S, Lam JT, Sims N, et al. Actionable Patient Safety Solution (APSS) #3D: Pediatric Adverse Drug Events. Patient Safety Movement Foundation. February 2017.
Lam JT, Salazar L. New combination antiviral for the treatment of hepatitis C. Am J Health-Syst Pharm 2016;73(14):1042-1050.
Lam JT, Yamaki J, Kayali Z. Advances in hepatitis C treatment: At the crossroads. J Nurse Pract. 2015;11:669-679.
Lam JT. Hepatitis C: In The Crosshairs. Chapman Living Textbook. Orange County Register. January 5, 2015. (http://www.ocregister.com/articles/treatment-647184-hcv-infected.html).
Gutierrez MA, Lam JT, Shaepper MA. Biological Basis for Understanding Psychiatric Treatments. In: Foundations of Psychiatric Mental Health Nursing, 7th ed. Varcarolis EM, Halter MJ (Eds.), 2013:37-62.
Lam JT, Jacob S. Boceprevir: A new protease inhibitor for hepatitis C treatment. Am J Health-Syst Pharm. 2012;69:2135 – 39.